Anemia resident survival guide: Difference between revisions
Line 137: | Line 137: | ||
==Management== | ==Management== | ||
{{familytree/start|summary=Anemia}} | {{familytree/start|summary=Anemia}} | ||
{{familytree | | | | | A01 | | | | | | | | | | | {{familytree | | | | | | | | | | | | | | | | | A01 | | | | | | | | | | | | | | | | | A01= '''Diagnostic work-up'''}} | ||
{{familytree | | | | | |,|-|-|-|-|-|-|-|-|-|-|-|+|-|-|-|-|-|-|-|-|-|-|-|-|.| | | | |}} | |||
{{familytree | | | | | |!| | | | | | | | | | | |!| | | | | | | | | | | | |!| | | | |}} | |||
{{familytree | | | | | B01 | | | | | | | | | | B02 | | | | | | | | | | | B03 | | | |B01=<div style="float: left; text-align: left; width:15em; padding:1em;">'''[[Iron deficiency anemia]]'''<br> | |||
:❑ [[Iron studies]]<br> | :❑ [[Iron studies]]<br> | ||
::❑ Decreased serum [[ferritin]]<br> ❑ Decreased serum [[iron]]<br>❑ Increased [[total iron binding capacity]]<br> ❑ Increased serum [[transferrin]]/ total iron binding capacity<br> ❑ Increased [[transferrin]] saturation<br> | ::❑ Decreased serum [[ferritin]]<br> ❑ Decreased serum [[iron]]<br>❑ Increased [[total iron binding capacity]]<br> ❑ Increased serum [[transferrin]]/ total iron binding capacity<br> ❑ Increased [[transferrin]] saturation<br> | ||
Line 152: | Line 155: | ||
:❑ [[Iron studies]]<br> | :❑ [[Iron studies]]<br> | ||
::❑ Normal or Increased serum [[ferritin]]<br> ❑ Decreased serum [[iron]]<br> ❑ Decreased [[transferrin]]<br> ❑ Normal or low-normal percent saturation of [[transferrin]]<br> | ::❑ Normal or Increased serum [[ferritin]]<br> ❑ Decreased serum [[iron]]<br> ❑ Decreased [[transferrin]]<br> ❑ Normal or low-normal percent saturation of [[transferrin]]<br> | ||
:❑ Increased [[cytokines]] (e.g., [[IL-6]], [[interferon-gamma]])<br> ❑ Increased [[acute phase reactant|acute phase reactants]] (e.g., [[fibrinogen]], [[erythrocyte sedimentation rate]] ([[ESR]]), [[C-reactive protein]] ([[CRP]]))<br> ❑ [[Rheumatologic assays]] or [[Serological tests]] (e.g., [[anti-nuclear antibody]], [[rheumatoid factor]], [[anti-CCP]], [[anti-dsDNA]])<br>| | :❑ Increased [[cytokines]] (e.g., [[IL-6]], [[interferon-gamma]])<br> ❑ Increased [[acute phase reactant|acute phase reactants]] (e.g., [[fibrinogen]], [[erythrocyte sedimentation rate]] ([[ESR]]), [[C-reactive protein]] ([[CRP]]))<br> ❑ [[Rheumatologic assays]] or [[Serological tests]] (e.g., [[anti-nuclear antibody]], [[rheumatoid factor]], [[anti-CCP]], [[anti-dsDNA]])<br>|B02=<div style="float: left; text-align: left; width:20em; padding:1em;"> | ||
'''[[Vitamin B12 deficiency]]'''<br> | '''[[Vitamin B12 deficiency]]'''<br> | ||
:❑ Decreased serum [[B12]] levels<br> ❑ Increased serum [[homocysteine]] levels <br> ❑ Increased serum [[methylmalonic acid]] levels<br> ❑ [[Anti-IF]] [[antibodies]]<br> ❑ [[Anti-parietal cell]] [[antibodies]]<br> | :❑ Decreased serum [[B12]] levels<br> ❑ Increased serum [[homocysteine]] levels <br> ❑ Increased serum [[methylmalonic acid]] levels<br> ❑ [[Anti-IF]] [[antibodies]]<br> ❑ [[Anti-parietal cell]] [[antibodies]]<br> | ||
Line 165: | Line 168: | ||
:❑ [[Albumin]]<br> ❑ [[Total protein]]<br> ❑ [[Bilirubin]]<br> ❑ [[ALP]] ([[alkaline phosphatase]]), [[ALT]] ([[alanine transaminase]]), [[AST]] ([[aspartate aminotransferase]]), and [[GGT]] ([[gamma-glutamyl transpeptidase]])<br> ❑ [[LDH]] ([[lactate dehydrogenase]])<br> ❑ [[Prothrombin time]]<br> | :❑ [[Albumin]]<br> ❑ [[Total protein]]<br> ❑ [[Bilirubin]]<br> ❑ [[ALP]] ([[alkaline phosphatase]]), [[ALT]] ([[alanine transaminase]]), [[AST]] ([[aspartate aminotransferase]]), and [[GGT]] ([[gamma-glutamyl transpeptidase]])<br> ❑ [[LDH]] ([[lactate dehydrogenase]])<br> ❑ [[Prothrombin time]]<br> | ||
'''[[Hypothroidism]]<br> | '''[[Hypothroidism]]<br> | ||
:❑ Low serum [[T3]],[[T4]] levels<br> ❑ Low or elevated serum [[TSH]] levels<br>| | :❑ Low serum [[T3]],[[T4]] levels<br> ❑ Low or elevated serum [[TSH]] levels<br>|B03=<div style="float: left; text-align: left; width:15em; padding:1em;"> | ||
'''[[Hemolytic anemia]]'''<br> | '''[[Hemolytic anemia]]'''<br> | ||
:❑ Elevated [[total bilirubin]]<br> ❑ Elevated [[LDH]]<br> ❑ [[Direct antiglobulin test]] ([[DAT]]) ([[Coomb's test]])<br> ❑ [[Indirect antiglobulin test]] (indirect [[Coombs' test]])<br ❑ [[Osmotic fragility test]]<br> ❑ Urine [[hemosiderin]]<br> ❑ Urine [[hemoglobin]]<br>❑ [[Peripheral blood smear]]<br> | :❑ Elevated [[total bilirubin]]<br> ❑ Elevated [[LDH]]<br> ❑ [[Direct antiglobulin test]] ([[DAT]]) ([[Coomb's test]])<br> ❑ [[Indirect antiglobulin test]] (indirect [[Coombs' test]])<br ❑ [[Osmotic fragility test]]<br> ❑ Urine [[hemosiderin]]<br> ❑ Urine [[hemoglobin]]<br>❑ [[Peripheral blood smear]]<br> | ||
Line 180: | Line 183: | ||
::❑ [[Thrombocytopenia]]<br> ❑ [[Leucocytosis]] or [[Leucopenia]]<br> ❑ Absolute [[basophilia]] and [[eosinophilia]]<br> ❑ [[Neutrophilia]] or [[Neutropenia]]<br> Low or elevated [[leukocyte alkaline phosphatase]]<br>}} | ::❑ [[Thrombocytopenia]]<br> ❑ [[Leucocytosis]] or [[Leucopenia]]<br> ❑ Absolute [[basophilia]] and [[eosinophilia]]<br> ❑ [[Neutrophilia]] or [[Neutropenia]]<br> Low or elevated [[leukocyte alkaline phosphatase]]<br>}} | ||
{{familytree | | | | | |!| | | | | | | | | | | |!| | | | | | | | | | | | |!| | | | |}} | {{familytree | | | | | |!| | | | | | | | | | | |!| | | | | | | | | | | | |!| | | | |}} | ||
{{familytree | | | | | | {{familytree | | | | | |`|-|-|-|-|-|-|-|-|-|-|-|+|-|-|-|-|-|-|-|-|-|-|-|-|'| | | | |}} | ||
{{familytree | | | | | | | | | | | | | | | | | C01 | | | | | | | | | | | | | | | | |C01='''[[Treatments|Treatment]]'''<br>}} | |||
{{familytree | | | | | |,|-|-|-|-|-|-|-|-|-|-|-|+|-|-|-|-|-|-|-|-|-|-|-|-|.| | | | |}} | |||
{{familytree | | | | | |!| | | | | | | | | | | |!| | | | | | | | | | | | |!| | | | |}} | |||
{{familytree | | | | | D01 | | | | | | | | | | D02 | | | | | | | | | | | D03 | | | |D01=<div style="float: left; text-align: left; width:15em; padding:1em;"> | |||
'''[[Iron deficiency anemia]]'''<br> | '''[[Iron deficiency anemia]]'''<br> | ||
:❑ [[Iron supplements]]<br> ❑ [[Erythropoietin]]<br> ❑ [[Blood transfusion]]<br> | :❑ [[Iron supplements]]<br> ❑ [[Erythropoietin]]<br> ❑ [[Blood transfusion]]<br> | ||
Line 191: | Line 198: | ||
:❑ [[Pyridoxine]], [[thiamine]] and [[folic acid]] <br> ❑ [[Iron chelators]]<br> ❑ [[Blood transfusion]]<br> | :❑ [[Pyridoxine]], [[thiamine]] and [[folic acid]] <br> ❑ [[Iron chelators]]<br> ❑ [[Blood transfusion]]<br> | ||
'''[[Anemia of chronic disease]]'''<br> | '''[[Anemia of chronic disease]]'''<br> | ||
:❑ [[Iron supplements]]<br> ❑ [[Erythropoietin]]<br> ❑ [[Blood transfusion]]<br> ❑ [[Treat]] the underlying [[etiology|cause]]<br>| | :❑ [[Iron supplements]]<br> ❑ [[Erythropoietin]]<br> ❑ [[Blood transfusion]]<br> ❑ [[Treat]] the underlying [[etiology|cause]]<br>|D02=<div style="float: left; text-align: left; width:15em; padding:1em;"> | ||
'''[[Vitamin B12 deficiency]]'''<br> | '''[[Vitamin B12 deficiency]]'''<br> | ||
:❑ [[Vitamin B12 supplementation]]<br> ❑ [[Folic acid supplementation]]<br> ❑ [[Treat]] the [[etiology|cause]] of [[vitamin B12 deficiency]]<br> | :❑ [[Vitamin B12 supplementation]]<br> ❑ [[Folic acid supplementation]]<br> ❑ [[Treat]] the [[etiology|cause]] of [[vitamin B12 deficiency]]<br> | ||
Line 199: | Line 206: | ||
:❑ [[Treat]] the underlying [[etiology|cause]]<br> | :❑ [[Treat]] the underlying [[etiology|cause]]<br> | ||
'''[[Hypothyroidism]]'''<br> | '''[[Hypothyroidism]]'''<br> | ||
:❑ [[Thyroid hormone]] replacement therapy<br>| | :❑ [[Thyroid hormone]] replacement therapy<br>|D03=<div style="float: left; text-align: left; width:15em; padding:1em;"> | ||
'''[[Hemolytic anemia]]<br> | '''[[Hemolytic anemia]]<br> | ||
:❑ [[Blood transfusion]]<br> ❑ [[Erythropoietin]]<br> ❑ [[Immunosuppression]]<br> | :❑ [[Blood transfusion]]<br> ❑ [[Erythropoietin]]<br> ❑ [[Immunosuppression]]<br> |
Revision as of 15:03, 31 August 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: ; Chetan Lokhande, M.B.B.S [2]
Overview
Anemia is defined as a decrease in the oxygen-carrying capacity of the blood causing tissue hypoxia. It presents with a decrease in volume concentrations of hemoglobin (Hb), hematocrit, red blood cell indices like (MCV), and red blood cell count (RBC count). Anemia is defined as a hemoglobin concentration (Hb) of less than 12 g/dL in women and less than 13 g/dL in men, or alternatively, hematocrit of less than 36% in women and less than 40% in men.
Causes
Life Threatening Causes
Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.[1][2]
- Aplastic anemia
- Sickle cell anemia
- Hemolytic anemia
- Paroxysmal nocturnal hemoglobinuria
- Severe thalassemia
- Fanconi anemia
- Malaria
- Myelodysplastic syndrome
- Severe Hemorrhage
- Acute leukemia
- Disseminated intravascular coagulation (DIC)
Common causes
Common causes of anemia include:[3][4][5]
For a complete list of hemolytic anemia causes, click here
- Pregnancy
- Anemia of chronic disease
- Lead poisoning
- Liver disease
- Chronic renal disease
- Splenomegaly
- Bone marrow suppression
- Alcoholism
For a complete list of anemia causes, click here
Diagnosis
Management
Abbreviations and Formula
MCV = mean cell volume RDW = Red blood cell distribution width TIBC = total iron binding capacity HEENT = head, eyes, ears, nose, and throat CNS = central nervous system WBC = white blood cells GI = gastrointestinal SLE = systemic lupus erythematosus EBV = epstein-barr virus HIV = human immunodeficiency virus IL-6 = interleukin 6 T3 = triiodothyronine T4 = thyroxine TSH = thyroid stimulating hormone LDH = lactate dehydrogenase DMSA = dimercaptosuccinic acid
Do's
- Investigating and treating the underlying cause is the crucial part of anemia management.
- Pregnant women must be screened for iron deficiency and folate deficiency.
- A well-balanced diet rich in iron and vitamins must be prescribed.
- In iron deficiency anemia, advice vitamin C rich diet like citrus fruits. Vitamin C helps in iron absorption.
Don'ts
- Do not give folic acid supplementation unless Vitamin B12 deficiency is ruled out.
- Avoid food items (e.g., coffee, tea, egg whites) in iron deficiency anemia as they decrease the absorption of iron in the body.
References
- ↑ "Acute Anemia - StatPearls - NCBI Bookshelf".
- ↑ Chaparro CM, Suchdev PS (August 2019). "Anemia epidemiology, pathophysiology, and etiology in low- and middle-income countries". Ann. N. Y. Acad. Sci. 1450 (1): 15–31. doi:10.1111/nyas.14092. PMC 6697587 Check
|pmc=
value (help). PMID 31008520. - ↑ Chaparro CM, Suchdev PS (2019). "Anemia epidemiology, pathophysiology, and etiology in low- and middle-income countries". Ann N Y Acad Sci. 1450 (1): 15–31. doi:10.1111/nyas.14092. PMC 6697587 Check
|pmc=
value (help). PMID 31008520. - ↑ "Anemia - Clinical Methods - NCBI Bookshelf".
- ↑ 5.0 5.1 Phillips J, Henderson AC (2018). "Hemolytic Anemia: Evaluation and Differential Diagnosis". Am Fam Physician. 98 (6): 354–361. PMID 30215915.
- ↑ Green R, Datta Mitra A (2017). "Megaloblastic Anemias: Nutritional and Other Causes". Med Clin North Am. 101 (2): 297–317. doi:10.1016/j.mcna.2016.09.013. PMID 28189172.
- ↑ Camaschella, Clara; Longo, Dan L. (2015). "Iron-Deficiency Anemia". New England Journal of Medicine. 372 (19): 1832–1843. doi:10.1056/NEJMra1401038. ISSN 0028-4793.
- ↑ Muncie HL, Campbell J (2009). "Alpha and beta thalassemia". Am Fam Physician. 80 (4): 339–44. PMID 19678601.
- ↑ Bain, Barbara J (2014). "Lead poisoning". American Journal of Hematology. 89 (12): 1141–1141. doi:10.1002/ajh.23852. ISSN 0361-8609.
- ↑ Bottomley, Sylvia S.; Fleming, Mark D. (2014). "Sideroblastic Anemia". Hematology/Oncology Clinics of North America. 28 (4): 653–670. doi:10.1016/j.hoc.2014.04.008. ISSN 0889-8588.
- ↑ Roy, Cindy N. (2010). "Anemia of Inflammation". Hematology. 2010 (1): 276–280. doi:10.1182/asheducation-2010.1.276. ISSN 1520-4391.
- ↑ Hunt A, Harrington D, Robinson S (2014). "Vitamin B12 deficiency". BMJ. 349: g5226. doi:10.1136/bmj.g5226. PMID 25189324.
- ↑ Hoffbrand AV (1977). "Pathology of folate deficiency". Proc R Soc Med. 70 (2): 82–4. PMC 1542974. PMID 558612.
- ↑ "Folic Acid (Folate) Deficiency - StatPearls - NCBI Bookshelf".
- ↑ Marks, Peter W. (2013). "Hematologic Manifestations of Liver Disease". Seminars in Hematology. 50 (3): 216–221. doi:10.1053/j.seminhematol.2013.06.003. ISSN 0037-1963.
- ↑ "Hematologic Manifestations of Thyroid Disease. : The Endocrinologist".
- ↑ Bustinduy AL, Parraga IM, Thomas CL, Mungai PL, Mutuku F, Muchiri EM; et al. (2013). "Impact of polyparasitic infections on anemia and undernutrition among Kenyan children living in a Schistosoma haematobium-endemic area". Am J Trop Med Hyg. 88 (3): 433–40. doi:10.4269/ajtmh.12-0552. PMC 3592521. PMID 23324217.
- ↑ Dolberg, Osnat Jarchowsky; Levy, Yair (2014). "Idiopathic aplastic anemia: Diagnosis and classification". Autoimmunity Reviews. 13 (4–5): 569–573. doi:10.1016/j.autrev.2014.01.014. ISSN 1568-9972.
- ↑ Davis AS, Viera AJ, Mead MD (2014). "Leukemia: an overview for primary care". Am Fam Physician. 89 (9): 731–8. PMID 24784336.